Profile data is unavailable for this security.
About the company
Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing of the Tiger trademarks and owning and holding investments for the long-term. Its segments include Healthcare products, Investments and Others. The Company's Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment is engaged in long term investing activities, mainly in quoted securities in Asia. The Company's Others segment includes property division, which owns and leases out several investment properties in Asia, and leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand products include Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch and Tiger Balm Muscle Rub. Its Kwan Loong brand products include Kwan Loong Medicated and Oil Kwan Loong Refresher.
- Revenue in SGD (TTM)232.06m
- Net income in SGD216.57m
- Incorporated1969
- Employees595.00
- LocationHaw Par Corporation Ltd401 Commonwealth Drive#03-03 Haw Par Techno Centre 149598SingaporeSGP
- Phone+65 63379102
- Fax+65 63369232
- Websitehttps://www.hawpar.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liaoning Chengda Biotechnology Co Ltd | 327.89m | 78.25m | 2.11bn | 1.73k | 26.84 | 1.16 | -- | 6.43 | 1.01 | 1.01 | 4.26 | 23.41 | 0.1743 | 0.7061 | 1.61 | 1,016,911.00 | 4.16 | 10.63 | 4.27 | 11.01 | 81.48 | 85.74 | 23.87 | 39.56 | 20.80 | -- | 0.002 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Polaris Group | 1.47m | -70.86m | 2.14bn | -- | -- | 7.03 | -- | 1,459.73 | -2.28 | -2.28 | 0.0472 | 9.78 | 0.0038 | -- | 4.58 | -- | -18.71 | -16.55 | -20.12 | -17.96 | -24.76 | -- | -4,904.26 | -12,960.21 | 12.67 | -- | 0.141 | -- | 16.18 | -- | -37.05 | -- | 50.45 | -- |
| Sansure Biotech Inc | 223.94m | 71.62m | 2.16bn | 2.01k | 30.62 | 1.55 | -- | 9.66 | 0.6448 | 0.6448 | 2.06 | 12.77 | 0.1377 | 0.8274 | 1.41 | 599,646.90 | 4.14 | 26.74 | 4.69 | 30.97 | 74.82 | 67.47 | 30.06 | 42.01 | 7.94 | -- | 0.0589 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 334.79m | 95.84m | 2.18bn | 2.47k | 22.70 | 2.68 | -- | 6.50 | 1.18 | 1.18 | 4.11 | 9.95 | 0.36 | 2.68 | 6.66 | 727,792.60 | 10.31 | -- | 11.11 | -- | 39.78 | -- | 28.63 | -- | 5.51 | -- | 0.0551 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| Sawai Group Holdings Co Ltd | 1.52bn | 147.76m | 2.18bn | 3.39k | 14.79 | 1.19 | 8.26 | 1.44 | 392.06 | 311.79 | 4,029.61 | 4,854.95 | 0.474 | 1.21 | 2.85 | -- | 3.40 | 0.7104 | 4.60 | 0.9705 | 30.71 | 35.08 | 7.17 | 1.47 | 1.50 | 52.16 | 0.2755 | 88.14 | 8.04 | -0.8249 | 46.82 | -2.33 | 18.15 | 0.00 |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 507.82m | 95.31m | 2.19bn | 2.55k | 22.89 | 1.49 | -- | 4.31 | 0.5447 | 0.5447 | 2.90 | 8.35 | 0.2186 | 1.58 | 0.8134 | 1,071,832.00 | 4.06 | 3.48 | 5.61 | 4.78 | 46.09 | 38.93 | 18.56 | 10.08 | 2.35 | -- | 0.2862 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
| Haw Par Corporation Ltd | 232.06m | 216.57m | 2.19bn | 595.00 | 10.13 | 0.6311 | 9.85 | 9.45 | 0.9784 | 0.9784 | 1.05 | 15.70 | 0.0641 | 5.08 | 6.16 | -- | 5.98 | 4.73 | 6.16 | 4.85 | 58.13 | 54.42 | 93.32 | 85.35 | 5.35 | -- | 0.008 | 45.57 | 27.44 | -0.4885 | 46.02 | 3.88 | 18.24 | 5.92 |
| Peptidream Inc | 240.06m | 20.96m | 2.21bn | 603.00 | 105.22 | 6.43 | 52.63 | 9.22 | 18.85 | 18.85 | 215.77 | 308.51 | 0.4323 | 4.20 | 5.14 | 46,391,190.00 | 3.77 | -- | 4.38 | -- | 59.16 | -- | 8.73 | -- | 3.23 | 2.59 | 0.3505 | -- | 6.93 | -- | -59.81 | -- | -- | -- |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 219.92m | 38.77m | 2.25bn | 1.55k | 57.94 | 5.36 | -- | 10.21 | 0.9769 | 0.9769 | 5.54 | 10.55 | 0.3743 | 1.21 | 4.71 | 764,598.40 | 6.69 | 5.86 | 9.15 | 7.59 | 63.15 | 55.41 | 17.87 | 17.20 | 1.08 | 33.77 | 0.3356 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 606.73m | 84.39m | 2.28bn | 2.88k | 27.05 | 3.13 | -- | 3.76 | 1.05 | 1.05 | 7.56 | 9.08 | 0.6482 | 5.87 | 11.13 | 1,130,851.00 | 9.26 | 10.82 | 11.03 | 13.47 | 42.87 | 41.18 | 14.29 | 14.08 | 5.18 | -- | 0.0729 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Holder | Shares | % Held |
|---|---|---|
| First Eagle Investment Management LLCas of 06 Mar 2023 | 23.35m | 10.55% |
| Kayne Anderson Rudnick Investment Management LLCas of 17 Aug 2023 | 11.22m | 5.07% |
| Asset Value Investors Ltd.as of 31 Jan 2024 | 1.86m | 0.84% |
| Dimensional Fund Advisors LPas of 30 Apr 2024 | 1.33m | 0.60% |
| Burgundy Asset Management Ltd.as of 30 Apr 2024 | 945.70k | 0.43% |
| Invesco Advisers, Inc.as of 31 Mar 2021 | 715.40k | 0.32% |
| First Sentier Investors (Singapore)as of 31 Jan 2024 | 695.30k | 0.31% |
| WCM Investment Management LLCas of 31 Mar 2024 | 654.40k | 0.30% |
| Healthinvest Partners ABas of 30 Jun 2022 | 580.00k | 0.26% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 571.20k | 0.26% |
